DE69618934T2 - Verbesserte organische zusammensetzungen - Google Patents
Verbesserte organische zusammensetzungenInfo
- Publication number
- DE69618934T2 DE69618934T2 DE69618934T DE69618934T DE69618934T2 DE 69618934 T2 DE69618934 T2 DE 69618934T2 DE 69618934 T DE69618934 T DE 69618934T DE 69618934 T DE69618934 T DE 69618934T DE 69618934 T2 DE69618934 T2 DE 69618934T2
- Authority
- DE
- Germany
- Prior art keywords
- organic compositions
- improved organic
- granules
- andb
- comprisinga
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9505032.4A GB9505032D0 (en) | 1995-03-13 | 1995-03-13 | Improvements in or relating to organic compositions |
PCT/GB1996/000514 WO1996028141A1 (en) | 1995-03-13 | 1996-03-05 | Improvements in or relating to organic compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69618934D1 DE69618934D1 (de) | 2002-03-14 |
DE69618934T2 true DE69618934T2 (de) | 2002-09-12 |
Family
ID=10771122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69618934T Expired - Lifetime DE69618934T2 (de) | 1995-03-13 | 1996-03-05 | Verbesserte organische zusammensetzungen |
Country Status (21)
Country | Link |
---|---|
US (1) | US6306789B1 (de) |
EP (1) | EP0814771B1 (de) |
JP (1) | JPH11501652A (de) |
KR (1) | KR19980702970A (de) |
CN (1) | CN1126533C (de) |
AT (1) | ATE212539T1 (de) |
AU (1) | AU712464B2 (de) |
BR (1) | BR9607234A (de) |
CZ (1) | CZ274497A3 (de) |
DE (1) | DE69618934T2 (de) |
ES (1) | ES2167546T3 (de) |
GB (2) | GB9505032D0 (de) |
HK (1) | HK1011291A1 (de) |
HU (1) | HUP9900800A3 (de) |
MX (1) | MX9706992A (de) |
NO (1) | NO974194D0 (de) |
NZ (1) | NZ302741A (de) |
PL (1) | PL184407B1 (de) |
TR (1) | TR199700943T1 (de) |
WO (1) | WO1996028141A1 (de) |
ZA (1) | ZA962012B (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2332522A3 (de) * | 1998-03-19 | 2011-12-07 | Bristol-Myers Squibb Company | Zweiphasig kontrolliertes Verabreichungssystem für hochlösliche Arzneimittel und verwandtes Verfahren |
GB9809347D0 (en) * | 1998-05-05 | 1998-07-01 | Reckitt & Colmann Prod Ltd | Compositions |
IN190017B (de) * | 1999-01-25 | 2003-05-31 | Panacea Biotech Ltd | |
AU2141202A (en) | 2000-12-05 | 2002-06-18 | Alexander Macgregor | Hydrostatic delivery system for controlled delivery of agent |
AU2002319653A1 (en) * | 2001-07-20 | 2003-03-03 | Samir Mitragotri | Method for oral drug delivery |
US6572889B1 (en) * | 2002-03-07 | 2003-06-03 | Noveon Ip Holdings Corp. | Controlled release solid dosage carbamazepine formulations |
US7198653B2 (en) | 2003-07-31 | 2007-04-03 | Delavau Llc | Calcium carbonate granulation |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US8679545B2 (en) | 2005-11-12 | 2014-03-25 | The Regents Of The University Of California | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
US8324192B2 (en) | 2005-11-12 | 2012-12-04 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US9138414B1 (en) | 2006-09-15 | 2015-09-22 | Delavau Llc | Calcium supplement having enhanced absorption |
US20120027855A1 (en) | 2007-07-06 | 2012-02-02 | Lupin Limited | Pharmaceutical compositions for gastrointestinal drug delivery |
WO2009008006A2 (en) * | 2007-07-06 | 2009-01-15 | Lupin Limited | Pharmaceutical compositions for gastrointestinal drug delivery |
EP2942053A1 (de) | 2007-07-06 | 2015-11-11 | Lupin Limited | Pharmazeutische Zusammensetzungen zur Wirkstoffverabreichung im Magen-Darm-Trakt |
US20100216754A1 (en) * | 2007-11-13 | 2010-08-26 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
WO2009064458A2 (en) * | 2007-11-13 | 2009-05-22 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
US20090131386A1 (en) * | 2007-11-13 | 2009-05-21 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
US20090123551A1 (en) * | 2007-11-13 | 2009-05-14 | Meritage Pharma, Inc. | Gastrointestinal delivery systems |
US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
RU2499592C2 (ru) | 2008-04-21 | 2013-11-27 | Отономи, Инк. | Фармацевтическая композиция для лечения ушных заболеваний |
US20090264392A1 (en) * | 2008-04-21 | 2009-10-22 | Meritage Pharma, Inc. | Treating eosinophilic esophagitis |
JP5421366B2 (ja) | 2008-07-21 | 2014-02-19 | オトノミ―,インク. | 制御放出性の耳の構造体調節および生来の免疫システム調節化合物および耳の障害の処置のための方法 |
US8784870B2 (en) * | 2008-07-21 | 2014-07-22 | Otonomy, Inc. | Controlled release compositions for modulating free-radical induced damage and methods of use thereof |
HUE051538T2 (hu) | 2008-08-20 | 2021-03-01 | Univ California | Kortikoszteroidok a gyomor-bél traktus gyulladásos betegségeinek kezelésére |
US11931227B2 (en) | 2013-03-15 | 2024-03-19 | Cook Medical Technologies Llc | Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding |
AU2014237970B2 (en) * | 2013-03-15 | 2017-01-05 | Cook Medical Technologies Llc | Adhesive medical products and methods for treating gastrointestinal lesions |
JP7023461B2 (ja) | 2015-07-28 | 2022-02-22 | オトノミ―,インク. | 耳の疾病の処置のためのtrkb又はtrkcアゴニスト組成物及び方法 |
KR20190024983A (ko) | 2016-06-29 | 2019-03-08 | 오토노미, 인코포레이티드 | 트리글리세라이드 귀 제제 및 이의 용도 |
US11452798B2 (en) | 2017-09-27 | 2022-09-27 | Cook Medical Technologies Llc | Crosslinking submucosal injectate system |
WO2019154895A1 (en) | 2018-02-08 | 2019-08-15 | Strekin Ag | Gel formulation for preventing or treating hearing loss |
CN114904007B (zh) * | 2022-04-24 | 2024-04-05 | 南京紫鸿生物科技有限公司 | 一种提高卡波姆的堆积密度的方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60237054A (ja) | 1984-05-10 | 1985-11-25 | Nippon Kayaku Co Ltd | アミノ酸の晶析法 |
GB8428952D0 (en) | 1984-11-16 | 1984-12-27 | Beecham Group Plc | Formulations |
US4772475A (en) * | 1985-03-08 | 1988-09-20 | Yamanouchi Pharmaceutical Co., Ltd. | Controlled-release multiple units pharmaceutical formulation |
US5057317A (en) | 1987-03-24 | 1991-10-15 | Chugai Seiyaku Kabushiki Kaisha | Slow-release pharmaceutical agent |
EP0297866A3 (de) | 1987-07-01 | 1989-12-13 | The Boots Company PLC | Arzneimittel |
GB9010039D0 (en) * | 1990-05-03 | 1990-06-27 | Reckitt & Colmann Prod Ltd | Medicament preparation |
DE4036757A1 (de) * | 1990-11-17 | 1992-05-21 | Bayer Ag | Antazida-zubereitung mit verlaengerter magenverweilzeit |
TW209174B (de) * | 1991-04-19 | 1993-07-11 | Takeda Pharm Industry Co Ltd | |
US5350584A (en) * | 1992-06-26 | 1994-09-27 | Merck & Co., Inc. | Spheronization process using charged resins |
ATE192932T1 (de) * | 1993-09-09 | 2000-06-15 | Takeda Chemical Industries Ltd | Formulierung enthaltend einen antibakteriellen und einen antiulcus wirkstoff |
-
1995
- 1995-03-13 GB GBGB9505032.4A patent/GB9505032D0/en active Pending
-
1996
- 1996-03-05 CZ CZ972744A patent/CZ274497A3/cs unknown
- 1996-03-05 NZ NZ302741A patent/NZ302741A/xx unknown
- 1996-03-05 BR BR9607234A patent/BR9607234A/pt not_active IP Right Cessation
- 1996-03-05 TR TR97/00943T patent/TR199700943T1/xx unknown
- 1996-03-05 ES ES96904957T patent/ES2167546T3/es not_active Expired - Lifetime
- 1996-03-05 WO PCT/GB1996/000514 patent/WO1996028141A1/en active IP Right Grant
- 1996-03-05 AT AT96904957T patent/ATE212539T1/de not_active IP Right Cessation
- 1996-03-05 GB GB9604678A patent/GB2298790B/en not_active Revoked
- 1996-03-05 CN CN96192524A patent/CN1126533C/zh not_active Expired - Lifetime
- 1996-03-05 MX MX9706992A patent/MX9706992A/es unknown
- 1996-03-05 EP EP96904957A patent/EP0814771B1/de not_active Expired - Lifetime
- 1996-03-05 JP JP8527355A patent/JPH11501652A/ja active Pending
- 1996-03-05 AU AU48868/96A patent/AU712464B2/en not_active Expired
- 1996-03-05 HU HU9900800A patent/HUP9900800A3/hu unknown
- 1996-03-05 KR KR1019970706378A patent/KR19980702970A/ko not_active Application Discontinuation
- 1996-03-05 DE DE69618934T patent/DE69618934T2/de not_active Expired - Lifetime
- 1996-03-13 ZA ZA962012A patent/ZA962012B/xx unknown
-
1997
- 1997-09-11 NO NO974194A patent/NO974194D0/no not_active Application Discontinuation
- 1997-09-12 PL PL96322065A patent/PL184407B1/pl unknown
-
1998
- 1998-11-30 HK HK98112458A patent/HK1011291A1/xx not_active IP Right Cessation
-
1999
- 1999-10-12 US US09/416,400 patent/US6306789B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GB9604678D0 (en) | 1996-05-01 |
US6306789B1 (en) | 2001-10-23 |
GB2298790B (en) | 1999-06-30 |
GB9505032D0 (en) | 1995-05-03 |
NO974194L (no) | 1997-09-11 |
CN1126533C (zh) | 2003-11-05 |
ZA962012B (en) | 1996-09-26 |
PL184407B1 (pl) | 2002-10-31 |
TR199700943T1 (xx) | 1998-02-21 |
KR19980702970A (ko) | 1998-09-05 |
DE69618934D1 (de) | 2002-03-14 |
JPH11501652A (ja) | 1999-02-09 |
BR9607234A (pt) | 1997-11-11 |
CZ274497A3 (cs) | 1998-03-18 |
PL322065A1 (en) | 1998-01-05 |
AU712464B2 (en) | 1999-11-04 |
AU4886896A (en) | 1996-10-02 |
HUP9900800A3 (en) | 2001-02-28 |
ES2167546T3 (es) | 2002-05-16 |
EP0814771B1 (de) | 2002-01-30 |
CN1178458A (zh) | 1998-04-08 |
NO974194D0 (no) | 1997-09-11 |
HUP9900800A2 (hu) | 1999-07-28 |
HK1011291A1 (en) | 1999-07-09 |
GB2298790A (en) | 1996-09-18 |
ATE212539T1 (de) | 2002-02-15 |
WO1996028141A1 (en) | 1996-09-19 |
MX9706992A (es) | 1997-11-29 |
NZ302741A (en) | 1999-08-30 |
EP0814771A1 (de) | 1998-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69618934T2 (de) | Verbesserte organische zusammensetzungen | |
DE59707812D1 (de) | Opioidantagonisthaltige galenische formulierung | |
AU3357800A (en) | Method of preparing alkylated salicylamides | |
ATE288255T1 (de) | Polares bukkales spray | |
ES2194732T3 (es) | Composiciones farmaceuticas orales de liberacion controlada de mesalazina. | |
DK1183014T3 (da) | Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse | |
WO2003079972A3 (en) | Active agent delivery systems and methods for protecting and administering active agents | |
BR0311530A (pt) | Compostos e método de liberação para droga transmucosal e para crio-proteção | |
NO20001567L (no) | Bioadhesive sammensetninger og fremgangsmÕter for topisk administrering av aktive midler | |
PL348734A1 (en) | New sustained release oral formulations | |
GB0122318D0 (en) | Organic compounds | |
ATE417622T1 (de) | Regulation gastrointestinaler beweglichkeit | |
NO2013019I2 (no) | Aliskiren eller et farmasøytisk akseptabelt salt derav, og hydroklortiazid eller et farmasøytisk akseptabelt salt derav. | |
IT1275816B1 (it) | Composizioni farmaceutiche solide per uso vaginale | |
WO2003041656A3 (en) | Soluble drug extended release system | |
TR200200683T2 (tr) | Oral kontrollü salıverme formülasyonları. | |
CA2214979A1 (en) | Improvements in or relating to organic compositions | |
BR9506507A (pt) | Forma galênica de derivados de 5-nitro-imadazol composiçoes farmacêuticas microgrânulos gastro-protegidos de derivados de 5-nitro-imidazol e produto da combinaçao | |
文案 et al. | SHINO FOR | |
CA2252038A1 (en) | Buccal polar spray or capsule | |
CO4910116A1 (es) | Formulacion de liberacion controlada para farmacos basicos escasamente solubles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8328 | Change in the person/name/address of the agent |
Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336 |
|
8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |